CLINICAL_TRIALS
withdrawal
· 2017-11-07
Clinical Trial Update: ACTH Treatment of APOL1- Associated Nephropathy [NA]
Summary
The clinical trial evaluating ACTH treatment for APOL1-associated nephropathy has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Wake Forest University Health Sciences | Conditions: Kidney Disease | NA | Status: WITHDRAWN